FDA Commissioner Marty Makary named Vinay Prasad the next director of the Center for Biologics Evaluation and Research on Tuesay. Numberous media outfits cited an internal email from Makary to staff members earlier in the day that announced Prasad's new position to head up biologics at the FDA. 

Vaccine and immunotherapies companies saw their share prices drop after the new was released of the appointment, presumably as 

Prasad has been a sharp critic of the Covid-19 vaccine for children and a critic of his predecessor, Peter Marks. 

Prasad has published over 500 academic articles and "done extensive research in the field of oncology and has presented at hundreds of scientific and medical conferences." "He is also the author of the books, "Malignant: How Bad Policy and Bad Evidence Harm People with Cancer" and "Ending Medical Reversal: Improving Outcomes, Saving Lives.""

Sounds like Big Pharma and Sickcare are worried these days! Good.